Analysts Are Increasing Price Targets of These 5 Stocks

Page 5 of 5

01. 89bio, Inc. (NASDAQ:ETNB)

Upside Potential: 95%

89bio, Inc. (NASDAQ:ETNB) is an American biotechnology company based in San Francisco, California. The firm develops treatments for liver and heart diseases. BTIG analyst Justin Zelin on June 30 revised the price target for 89bio, Inc. (NASDAQ:ETNB), increasing it from $30 to $37. This upgrade reflects a more optimistic outlook on the stock’s performance. With this new target, investors may expect a higher valuation and potential returns. The adjusted price target suggests that BTIG believes 89bio, Inc. (NASDAQ:ETNB) has strong growth potential and could deliver better-than-expected results in the market. Justin Zelin’s assessment highlights confidence in the company’s prospects and may attract increased attention from investors looking for promising investment opportunities.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out 10 Special Situation Penny Stocks With Near Term Catalysts and 10 Dow Stocks Billionaires Are Loading Up On.

Page 5 of 5